158 related articles for article (PubMed ID: 9302201)
1. Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients.
Ismail TF; Wasfy MO; Oyofo BA; Mansour MM; El-Berry HM; Churilla AM; Eldin SS; Peruski LF
Clin Diagn Lab Immunol; 1997 Sep; 4(5):536-9. PubMed ID: 9302201
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
Strid MA; Engberg J; Larsen LB; Begtrup K; Mølbak K; Krogfelt KA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):314-9. PubMed ID: 11238214
[TBL] [Abstract][Full Text] [Related]
3. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay.
Herbrink P; van den Munckhof HA; Bumkens M; Lindeman J; van Dijk WC
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):388-93. PubMed ID: 3137040
[TBL] [Abstract][Full Text] [Related]
4. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.
Villa NA; Okhuysen PC; Flores-Figueroa J; Jiang ZD; Belkind-Gerson J; Paredes M; Mohamed JA; Nair P; Carlin L; DuPont HL
J Travel Med; 2011; 18(1):56-8. PubMed ID: 21199144
[TBL] [Abstract][Full Text] [Related]
5. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.
Blaser MJ; Duncan DJ
Infect Immun; 1984 May; 44(2):292-8. PubMed ID: 6715034
[TBL] [Abstract][Full Text] [Related]
6. [Frequency of antibodies to the recombinant protein P39 of C. jejuni in patients with gastrointestinal disorders and reactive arthritis in Poland].
Rokosz-Chudziak N; Rastawicki W
Med Dosw Mikrobiol; 2014; 66(3-4):195-207. PubMed ID: 25804073
[TBL] [Abstract][Full Text] [Related]
7. Multifocal motor neuropathy and Campylobacter jejuni reactivity.
Terenghi F; Allaria S; Scarlato G; Nobile-Orazio E
Neurology; 2002 Jul; 59(2):282-4. PubMed ID: 12136073
[TBL] [Abstract][Full Text] [Related]
8. Single and multiple acid extract antigens in Campylobacter serology.
Rautelin H; Kosunen TU
Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):277-81. PubMed ID: 3314336
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations.
Islam D; Lewis MD; Srijan A; Bodhidatta L; Aksomboon A; Gettayacamin M; Baqar S; Scott D; Mason CJ
Vaccine; 2006 May; 24(18):3762-71. PubMed ID: 16098634
[TBL] [Abstract][Full Text] [Related]
10. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
11. [Antibody response following Campylobacter infections determined by ELISA].
Engberg JH; Strid MA; Mølbak K; Krogfelt KA
Ugeskr Laeger; 2003 Jun; 165(24):2485-6. PubMed ID: 12872469
[TBL] [Abstract][Full Text] [Related]
12. ELISA for Campylobacter jejuni antibodies in Israeli children with diarrhea and in healthy soldiers.
Schwartz D; Melamed I; Cohen D; Konforti N; Goldhar J
Isr J Med Sci; 1990 Jun; 26(6):319-24. PubMed ID: 2380033
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
[TBL] [Abstract][Full Text] [Related]
14. No signs of Campylobacter jejuni/coli-related antibodies in patients with active ankylosing spondylitis.
Andreasen JJ; Ringsdal VS; Helin P
APMIS; 1991 Aug; 99(8):735-8. PubMed ID: 1677583
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects.
Tribble DR; Baqar S; Carmolli MP; Porter C; Pierce KK; Sadigh K; Guerry P; Larsson CJ; Rockabrand D; Ventone CH; Poly F; Lyon CE; Dakdouk S; Fingar A; Gilliland T; Daunais P; Jones E; Rymarchyk S; Huston C; Darsley M; Kirkpatrick BD
Clin Infect Dis; 2009 Nov; 49(10):1512-9. PubMed ID: 19842970
[TBL] [Abstract][Full Text] [Related]
16. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.
Kirkpatrick BD; Lyon CE; Porter CK; Maue AC; Guerry P; Pierce KK; Carmolli MP; Riddle MS; Larsson CJ; Hawk D; Dill EA; Fingar A; Poly F; Fimlaid KA; Hoq F; Tribble DR
Clin Infect Dis; 2013 Oct; 57(8):1106-13. PubMed ID: 23840001
[TBL] [Abstract][Full Text] [Related]
17. [Myocarditis and pericarditis in connection with Campylobacter jejuni infection].
Melby K; von der Lippe E; Bruun JN
Tidsskr Nor Laegeforen; 1992 Feb; 112(4):475-6. PubMed ID: 1553694
[TBL] [Abstract][Full Text] [Related]
18. Identification of Campylobacter jejuni and Campylobacter coli antigens with mucosal and systemic antibodies.
Wu SJ; Pacheco ND; Oprandy JJ; Rollwagen FM
Infect Immun; 1991 Aug; 59(8):2555-9. PubMed ID: 1855976
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni.
Svedhem A; Gunnarsson H; Kaijser B
J Infect Dis; 1983 Jul; 148(1):82-92. PubMed ID: 6411829
[TBL] [Abstract][Full Text] [Related]
20. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
